Announced Wed, 4 Mar · 17:01 IST

SOLARA: Intimation regarding the closure of wholly owned subsidiary of the Company in Brazil.

Strategic Transactions View source PDF

SOLARA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Solara Active Pharma Sciences has closed its wholly owned Brazilian subsidiary, Solara Active Pharma Sciences LTDA, by voluntarily deregistering it with the Federal Revenue of Brazil, effective July 30, 2025. The subsidiary was non-operating and contributed nil to both the consolidated turnover and net worth for the financial year ended March 31, 2025. This follows a prior intimation from February 21, 2025, and is part of routine corporate housekeeping. No consideration was involved as this was a voluntary deregistration, not a sale or disposal.

Likely market impact

Minimal to no impact on shareholders or the stock price, as the Brazil entity was dormant and had zero contribution to revenue or net worth. This is a non-material housekeeping action to streamline the company's corporate structure.